Aktiespot

Aktie

VYCO

Geschlossen
$0.06900.0000 (0.00%)
Chart wird geladen...

N/A

Eröffnung0.0600
Hoch0.0690
Tief0.0600
Volumen28k
P/E
MarktkapitalisierungN/A
52-Wochen-Hoch0.2000
52-Wochen-Tief0.0320
Durchschn. Volumen7.46k
DividendeN/A
Beta-0.53
EPS0.0000

Über null Aktie

Vycor Medical, Inc. designs, develops, and markets neurological medical devices and therapies in the United States and Europe. The company operates through two segments: Vycor Medical and NovaVision. Its Vycor Medical segment provides devices for neurosurgery comprising ViewSite Brain Access System, a retraction and access system for brain and spine surgeries. The NovaVision segment offers non-invasive computer-based rehabilitation therapies targeted at people who have impaired vision as a result of stroke or other brain injury. It has a license agreement with a German-based partner. It primarily serves hospitals and medical professionals. The company was incorporated in 2005 and is headquartered in Boca Raton, Florida. Vycor Medical, Inc. operates as a subsidiary of Fountainhead Capital Management Ltd.

Unternehmensinformationen

Börse: OTC Markets OTCQB (OQB)
Sektor: Sundhed
Branche: Medicinsk udstyr
Adresse:
951 Broken Sound Boulevard
33487 Boca Raton, United States
Telefon: + 561 558 2020

Analystenempfehlungen

Diese Übersicht gibt einen schnellen Einblick, wie Analysten das Aktienpotenzial basierend auf ihren neuesten Analysen und Kurszielen bewerten.

Niedrigstes Kursziel
Durchschnittliches Kursziel
Median Kursziel
Höchstes Kursziel

Andere sehen auch: